Boston Scientific Corporation
BSX
Rang in aandelen
#409
Deze bedrijfsbeschrijving is alleen in het Engels beschikbaar.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Aandeelprijs
$41.88
Laatst gesynchroniseerd: 2026-10-30
Marktkapitalisatie
$60.69B
Verandering (1 dag)
-1.89%
Verandering (1 jaar)
-58.42%
Land
US
Aandelendata: Financial Modeling Prep·Bijgewerkt op ·Geen beleggingsadvies·Zo rekenen we
Handel Boston Scientific Corporation (BSX)
Categorie
Healthcare
Aandelsplitsingen voor Boston Scientific Corporation (BSX)
Het aandeel Boston Scientific Corporation (symbool: BSX) heeft in totaal 2 splitsingen ondergaan.
De meest recente splitsing vond plaats op Nov 06, 2003.
Eén aandeel BSX dat vóór Dec 01, 1998 werd gekocht, staat nu gelijk aan 4 aandelen BSX.
De meest recente splitsing vond plaats op Nov 06, 2003.
Eén aandeel BSX dat vóór Dec 01, 1998 werd gekocht, staat nu gelijk aan 4 aandelen BSX.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2003-11-06 | 2:1 | x2 | x4 |
| 1998-12-01 | 2:1 | x2 | x2 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 0 | - |
DE
|
|
| 3 | x12 |
US
|
Vragen over de aandelensplitsingen van Boston Scientific Corporation
Hoe vaak heeft Boston Scientific Corporation een aandelensplitsing doorgevoerd?
Boston Scientific Corporation (BSX) heeft 2 keer een aandelensplitsing doorgevoerd. De eerste was op 1 dec. 1998, de meest recente op 6 nov. 2003.
Hoeveel aandelen zou je nu hebben als je vóór 1 dec. 1998 één aandeel Boston Scientific Corporation had gekocht?
Door alle aandelensplitsingen is één aandeel dat vóór 1 dec. 1998 werd gekocht nu goed voor 4.00 aandelen.